Why the study?
What is the frequency of hemorrhagic and thrombotic complications associated with long-term oral anticoagulation in cancer patients?
Population
25 patients with cancer managed in an outpatient anticoagulation clinic
Design
Cohort
Follow-up
186 patient-months total
Authors
Loading...
High complication rates during anticoagulation in cancer patients warrant monitoring; leaves open optimal regimens via prospective trials.
What is the frequency of hemorrhagic and thrombotic complications associated with long-term oral anticoagulation in cancer patients?
Cancer patients requiring long-term oral anticoagulation face a high risk of both hemorrhagic and thrombotic complications, highlighting the need for close monitoring in specialized anticoagulation clinics.
Krauth et al. (1987) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: